Condition: MASH - Metabolic Dysfunction-Associated Steatohepatitis · T2DM (Type 2 Diabetes Mellitus) · Sponsor: Shanghai Jiao Tong University School of Medicine
This trial aims to evaluate the efficacy and safety of chiglitazar as a combination therapy for patients with MASH and T2DM.
This description comes directly from the study's public registry record.
Hai Li, professor · +86 13818525494 · haili_17@126.com
Lianyong Liu, professor · +86 13564144866 · chinallu@163.com
Always discuss trial participation with your own doctor first.
| Ditan Hospital of integrated traditional Chinese and Western Medicine Center | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Southwest Hospital of Third Military Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Fujian Medical University | Fuzhou, Fujian, China | Not Yet Recruiting |
| The Third Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Southern Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Wuhan Union Hospital of Huazhong University of Science and Technology | Wuhan, Hebei, China | Not Yet Recruiting |
| Taihe Hospital | Shiyan, Hubei, China | Not Yet Recruiting |
| Xiangya hospital of Central South University | Changsha, Hunan, China | Not Yet Recruiting |
| The First Affiliated Hospital of Jilin University | Changchun, Jilin, China | Not Yet Recruiting |
| Renji hospital of Shanghai Jiao Tong University School of Medical | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
| Ruijin Hospital of Shanghai Jiaotong University School of Medicine | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
| Shanghai Public Health Clinical Center | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07303803